The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Recombinant Antibody Service Market Research Report 2024

Global Recombinant Antibody Service Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1742341

No of Pages : 112

Ask Your Query

Synopsis
Global Recombinant Antibody Service market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Recombinant Antibody Service market research.

Key companies engaged in the Recombinant Antibody Service industry include GenScript Biotech Corporation, Abcam plc, Creative Biolabs, Absolute Antibody Ltd., Thermo Fisher Scientific Inc., ProteoGenix, Bio-Rad Laboratories, Inc., Rockland Immunochemicals Inc. and RayBiotech, Inc., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Recombinant Antibody Service were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Recombinant Antibody Service market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Recombinant Antibody Service market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • GenScript Biotech Corporation
  • Abcam plc
  • Creative Biolabs
  • Absolute Antibody Ltd.
  • Thermo Fisher Scientific Inc.
  • ProteoGenix
  • Bio-Rad Laboratories, Inc.
  • Rockland Immunochemicals Inc.
  • RayBiotech, Inc.
  • Novoprotein Scientific Inc.
  • Sino Biological Inc.
  • Abnova Corporation
  • ACROBiosystems
  • Fitzgerald Industries International
  • Boster Biological Technology Co., Ltd.
  • HyTest Ltd.
  • Randox Laboratories Ltd.
  • Agilent Technologies, Inc.
  • AnaSpec, Inc.
  • Epitomics International Inc.
  • Cell Signaling Technology, Inc.
  • OriGene Technologies, Inc.
  • Meridian Life Science Inc.
  • Enzo Life Sciences, Inc.
  • MabPlex Inc.

Segment by Type

  • Antibody Generation
  • Optimization
  • Engineering
  • Modification
  • Expression

Segment by Application

  • Biopharmaceuticals
  • Diagnostics
  • Research
  • Therapeutics

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

The Recombinant Antibody Service report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Antibody Service Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Antibody Generation
1.2.3 Optimization
1.2.4 Engineering
1.2.5 Modification
1.2.6 Expression
1.3 Market by Application
1.3.1 Global Recombinant Antibody Service Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Biopharmaceuticals
1.3.3 Diagnostics
1.3.4 Research
1.3.5 Therapeutics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Antibody Service Market Perspective (2018-2029)
2.2 Recombinant Antibody Service Growth Trends by Region
2.2.1 Global Recombinant Antibody Service Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Recombinant Antibody Service Historic Market Size by Region (2018-2023)
2.2.3 Recombinant Antibody Service Forecasted Market Size by Region (2024-2029)
2.3 Recombinant Antibody Service Market Dynamics
2.3.1 Recombinant Antibody Service Industry Trends
2.3.2 Recombinant Antibody Service Market Drivers
2.3.3 Recombinant Antibody Service Market Challenges
2.3.4 Recombinant Antibody Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Antibody Service Players by Revenue
3.1.1 Global Top Recombinant Antibody Service Players by Revenue (2018-2023)
3.1.2 Global Recombinant Antibody Service Revenue Market Share by Players (2018-2023)
3.2 Global Recombinant Antibody Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Recombinant Antibody Service Revenue
3.4 Global Recombinant Antibody Service Market Concentration Ratio
3.4.1 Global Recombinant Antibody Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Antibody Service Revenue in 2022
3.5 Recombinant Antibody Service Key Players Head office and Area Served
3.6 Key Players Recombinant Antibody Service Product Solution and Service
3.7 Date of Enter into Recombinant Antibody Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Antibody Service Breakdown Data by Type
4.1 Global Recombinant Antibody Service Historic Market Size by Type (2018-2023)
4.2 Global Recombinant Antibody Service Forecasted Market Size by Type (2024-2029)
5 Recombinant Antibody Service Breakdown Data by Application
5.1 Global Recombinant Antibody Service Historic Market Size by Application (2018-2023)
5.2 Global Recombinant Antibody Service Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Recombinant Antibody Service Market Size (2018-2029)
6.2 North America Recombinant Antibody Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Recombinant Antibody Service Market Size by Country (2018-2023)
6.4 North America Recombinant Antibody Service Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Recombinant Antibody Service Market Size (2018-2029)
7.2 Europe Recombinant Antibody Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Recombinant Antibody Service Market Size by Country (2018-2023)
7.4 Europe Recombinant Antibody Service Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Antibody Service Market Size (2018-2029)
8.2 Asia-Pacific Recombinant Antibody Service Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Recombinant Antibody Service Market Size by Region (2018-2023)
8.4 Asia-Pacific Recombinant Antibody Service Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Recombinant Antibody Service Market Size (2018-2029)
9.2 Latin America Recombinant Antibody Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Recombinant Antibody Service Market Size by Country (2018-2023)
9.4 Latin America Recombinant Antibody Service Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Antibody Service Market Size (2018-2029)
10.2 Middle East & Africa Recombinant Antibody Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Recombinant Antibody Service Market Size by Country (2018-2023)
10.4 Middle East & Africa Recombinant Antibody Service Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GenScript Biotech Corporation
11.1.1 GenScript Biotech Corporation Company Detail
11.1.2 GenScript Biotech Corporation Business Overview
11.1.3 GenScript Biotech Corporation Recombinant Antibody Service Introduction
11.1.4 GenScript Biotech Corporation Revenue in Recombinant Antibody Service Business (2018-2023)
11.1.5 GenScript Biotech Corporation Recent Development
11.2 Abcam plc
11.2.1 Abcam plc Company Detail
11.2.2 Abcam plc Business Overview
11.2.3 Abcam plc Recombinant Antibody Service Introduction
11.2.4 Abcam plc Revenue in Recombinant Antibody Service Business (2018-2023)
11.2.5 Abcam plc Recent Development
11.3 Creative Biolabs
11.3.1 Creative Biolabs Company Detail
11.3.2 Creative Biolabs Business Overview
11.3.3 Creative Biolabs Recombinant Antibody Service Introduction
11.3.4 Creative Biolabs Revenue in Recombinant Antibody Service Business (2018-2023)
11.3.5 Creative Biolabs Recent Development
11.4 Absolute Antibody Ltd.
11.4.1 Absolute Antibody Ltd. Company Detail
11.4.2 Absolute Antibody Ltd. Business Overview
11.4.3 Absolute Antibody Ltd. Recombinant Antibody Service Introduction
11.4.4 Absolute Antibody Ltd. Revenue in Recombinant Antibody Service Business (2018-2023)
11.4.5 Absolute Antibody Ltd. Recent Development
11.5 Thermo Fisher Scientific Inc.
11.5.1 Thermo Fisher Scientific Inc. Company Detail
11.5.2 Thermo Fisher Scientific Inc. Business Overview
11.5.3 Thermo Fisher Scientific Inc. Recombinant Antibody Service Introduction
11.5.4 Thermo Fisher Scientific Inc. Revenue in Recombinant Antibody Service Business (2018-2023)
11.5.5 Thermo Fisher Scientific Inc. Recent Development
11.6 ProteoGenix
11.6.1 ProteoGenix Company Detail
11.6.2 ProteoGenix Business Overview
11.6.3 ProteoGenix Recombinant Antibody Service Introduction
11.6.4 ProteoGenix Revenue in Recombinant Antibody Service Business (2018-2023)
11.6.5 ProteoGenix Recent Development
11.7 Bio-Rad Laboratories, Inc.
11.7.1 Bio-Rad Laboratories, Inc. Company Detail
11.7.2 Bio-Rad Laboratories, Inc. Business Overview
11.7.3 Bio-Rad Laboratories, Inc. Recombinant Antibody Service Introduction
11.7.4 Bio-Rad Laboratories, Inc. Revenue in Recombinant Antibody Service Business (2018-2023)
11.7.5 Bio-Rad Laboratories, Inc. Recent Development
11.8 Rockland Immunochemicals Inc.
11.8.1 Rockland Immunochemicals Inc. Company Detail
11.8.2 Rockland Immunochemicals Inc. Business Overview
11.8.3 Rockland Immunochemicals Inc. Recombinant Antibody Service Introduction
11.8.4 Rockland Immunochemicals Inc. Revenue in Recombinant Antibody Service Business (2018-2023)
11.8.5 Rockland Immunochemicals Inc. Recent Development
11.9 RayBiotech, Inc.
11.9.1 RayBiotech, Inc. Company Detail
11.9.2 RayBiotech, Inc. Business Overview
11.9.3 RayBiotech, Inc. Recombinant Antibody Service Introduction
11.9.4 RayBiotech, Inc. Revenue in Recombinant Antibody Service Business (2018-2023)
11.9.5 RayBiotech, Inc. Recent Development
11.10 Novoprotein Scientific Inc.
11.10.1 Novoprotein Scientific Inc. Company Detail
11.10.2 Novoprotein Scientific Inc. Business Overview
11.10.3 Novoprotein Scientific Inc. Recombinant Antibody Service Introduction
11.10.4 Novoprotein Scientific Inc. Revenue in Recombinant Antibody Service Business (2018-2023)
11.10.5 Novoprotein Scientific Inc. Recent Development
11.11 Sino Biological Inc.
11.11.1 Sino Biological Inc. Company Detail
11.11.2 Sino Biological Inc. Business Overview
11.11.3 Sino Biological Inc. Recombinant Antibody Service Introduction
11.11.4 Sino Biological Inc. Revenue in Recombinant Antibody Service Business (2018-2023)
11.11.5 Sino Biological Inc. Recent Development
11.12 Abnova Corporation
11.12.1 Abnova Corporation Company Detail
11.12.2 Abnova Corporation Business Overview
11.12.3 Abnova Corporation Recombinant Antibody Service Introduction
11.12.4 Abnova Corporation Revenue in Recombinant Antibody Service Business (2018-2023)
11.12.5 Abnova Corporation Recent Development
11.13 ACROBiosystems
11.13.1 ACROBiosystems Company Detail
11.13.2 ACROBiosystems Business Overview
11.13.3 ACROBiosystems Recombinant Antibody Service Introduction
11.13.4 ACROBiosystems Revenue in Recombinant Antibody Service Business (2018-2023)
11.13.5 ACROBiosystems Recent Development
11.14 Fitzgerald Industries International
11.14.1 Fitzgerald Industries International Company Detail
11.14.2 Fitzgerald Industries International Business Overview
11.14.3 Fitzgerald Industries International Recombinant Antibody Service Introduction
11.14.4 Fitzgerald Industries International Revenue in Recombinant Antibody Service Business (2018-2023)
11.14.5 Fitzgerald Industries International Recent Development
11.15 Boster Biological Technology Co., Ltd.
11.15.1 Boster Biological Technology Co., Ltd. Company Detail
11.15.2 Boster Biological Technology Co., Ltd. Business Overview
11.15.3 Boster Biological Technology Co., Ltd. Recombinant Antibody Service Introduction
11.15.4 Boster Biological Technology Co., Ltd. Revenue in Recombinant Antibody Service Business (2018-2023)
11.15.5 Boster Biological Technology Co., Ltd. Recent Development
11.16 HyTest Ltd.
11.16.1 HyTest Ltd. Company Detail
11.16.2 HyTest Ltd. Business Overview
11.16.3 HyTest Ltd. Recombinant Antibody Service Introduction
11.16.4 HyTest Ltd. Revenue in Recombinant Antibody Service Business (2018-2023)
11.16.5 HyTest Ltd. Recent Development
11.17 Randox Laboratories Ltd.
11.17.1 Randox Laboratories Ltd. Company Detail
11.17.2 Randox Laboratories Ltd. Business Overview
11.17.3 Randox Laboratories Ltd. Recombinant Antibody Service Introduction
11.17.4 Randox Laboratories Ltd. Revenue in Recombinant Antibody Service Business (2018-2023)
11.17.5 Randox Laboratories Ltd. Recent Development
11.18 Agilent Technologies, Inc.
11.18.1 Agilent Technologies, Inc. Company Detail
11.18.2 Agilent Technologies, Inc. Business Overview
11.18.3 Agilent Technologies, Inc. Recombinant Antibody Service Introduction
11.18.4 Agilent Technologies, Inc. Revenue in Recombinant Antibody Service Business (2018-2023)
11.18.5 Agilent Technologies, Inc. Recent Development
11.19 AnaSpec, Inc.
11.19.1 AnaSpec, Inc. Company Detail
11.19.2 AnaSpec, Inc. Business Overview
11.19.3 AnaSpec, Inc. Recombinant Antibody Service Introduction
11.19.4 AnaSpec, Inc. Revenue in Recombinant Antibody Service Business (2018-2023)
11.19.5 AnaSpec, Inc. Recent Development
11.20 Epitomics International Inc.
11.20.1 Epitomics International Inc. Company Detail
11.20.2 Epitomics International Inc. Business Overview
11.20.3 Epitomics International Inc. Recombinant Antibody Service Introduction
11.20.4 Epitomics International Inc. Revenue in Recombinant Antibody Service Business (2018-2023)
11.20.5 Epitomics International Inc. Recent Development
11.21 Cell Signaling Technology, Inc.
11.21.1 Cell Signaling Technology, Inc. Company Detail
11.21.2 Cell Signaling Technology, Inc. Business Overview
11.21.3 Cell Signaling Technology, Inc. Recombinant Antibody Service Introduction
11.21.4 Cell Signaling Technology, Inc. Revenue in Recombinant Antibody Service Business (2018-2023)
11.21.5 Cell Signaling Technology, Inc. Recent Development
11.22 OriGene Technologies, Inc.
11.22.1 OriGene Technologies, Inc. Company Detail
11.22.2 OriGene Technologies, Inc. Business Overview
11.22.3 OriGene Technologies, Inc. Recombinant Antibody Service Introduction
11.22.4 OriGene Technologies, Inc. Revenue in Recombinant Antibody Service Business (2018-2023)
11.22.5 OriGene Technologies, Inc. Recent Development
11.23 Meridian Life Science Inc.
11.23.1 Meridian Life Science Inc. Company Detail
11.23.2 Meridian Life Science Inc. Business Overview
11.23.3 Meridian Life Science Inc. Recombinant Antibody Service Introduction
11.23.4 Meridian Life Science Inc. Revenue in Recombinant Antibody Service Business (2018-2023)
11.23.5 Meridian Life Science Inc. Recent Development
11.24 Enzo Life Sciences, Inc.
11.24.1 Enzo Life Sciences, Inc. Company Detail
11.24.2 Enzo Life Sciences, Inc. Business Overview
11.24.3 Enzo Life Sciences, Inc. Recombinant Antibody Service Introduction
11.24.4 Enzo Life Sciences, Inc. Revenue in Recombinant Antibody Service Business (2018-2023)
11.24.5 Enzo Life Sciences, Inc. Recent Development
11.25 MabPlex Inc.
11.25.1 MabPlex Inc. Company Detail
11.25.2 MabPlex Inc. Business Overview
11.25.3 MabPlex Inc. Recombinant Antibody Service Introduction
11.25.4 MabPlex Inc. Revenue in Recombinant Antibody Service Business (2018-2023)
11.25.5 MabPlex Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock